Lysando
Business Services · Liechtenstein · 11-50 Employees
View Company Info for Free
Overview
Headquarters
91 Wangerbergstrasse, Triesenberg, Tries...Phone Number
+423 2625753Website
www.lysando.comRevenue
$6.5 MillionIndustry
About Lysando
Lysando Org Chart
Is Lysando your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Lysando had a recent Job posting/layoffs
Check if Lysando has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Lysando is spiking on competitors!
Product Launch: Get notified when Lysando launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Lysando
Earning: See what the market has to say on Lysando recently announced quarterly report
Funding: Get notified immidiatlly once Lysando has new funding data
Lysando, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Lysando as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Lysando is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Lysando is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Lysando.
Lysando Tech Stack
A closer look at the technologies used by Lysando
Lysando News & Media
Lysando Welcomes Healthcare Visionary Jorge Cortell to its Advisory Board
TRIESENBERG, Liechtenstein--(BUSINESS WIRE)-- #Artilysin--Lysando, leading biotech in antimicrobial proteins, proudly announces the addition of Mr. Jorge Cortell to its esteemed Advisory Board marking a significant milestone in the company's growth. As a serial entrepreneur and renowned visionary in healthcare technology he brings a wealth of expertise to Lysando's strategic direction. As Senior Advisor for Healthcare and Life Sciences at Harvard University Innovation Laboratories, and a technolArtilysin® - A Groundbreaking "Green Pharma” Solution
TRIESENBERG, Liechtenstein--(BUSINESS WIRE)-- #Artilysin--Lysando, the leading pioneer in the field of antimicrobial proteins has achieved significant milestones with its cutting-edge Artilysin® technology. This innovative platform has demonstrated a distinctive mode of action and exceptional versatility, positioning it at the forefront of the battle against resistant pathogenic bacteria. Embracing the "green pharma" philosophy, Lysando's Artilysin® molecules effectively target resistant pathogeAmicogen and Lysando: Novel Approach for the Treatment of Mastitis in Dairy Cows
TRIESENBERG, Liechtenstein--(BUSINESS WIRE)-- #Artilysin--Amicogen, a leading biotech company specializing in industrial enzyme production and drug development, has partnered with Lysando, an innovative biotech company with expertise in the development of antimicrobial Artilysin®, to address the rising issue of mastitis in dairy cows caused by multi-resistant bacteria. According to recent research, the overuse of antibiotics in animal husbandry has been driving a fast increase in multidrug-resisArtilysin®: Promising Approach Against Acinetobacter baumannii Infected Wounds
TRIESENBERG, Liechtenstein--(BUSINESS WIRE)-- #Artilysin--Severe wound infections increasingly prove to be a serious medical challenge. Complications particularly arise from the high number of infections caused by resistant or multi-resistant pathogens. "Infections with resistant bacteria remain the greatest threat to human health. Recently, the United Nations pointed out that in 2019 alone, almost five million deaths worldwide were caused by resistant pathogens", says Univ.-Prof. Dr. med. Volkh
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Lysando
Lysando AG specializes in combating resistant bacteria and hospital germs through innovative solutions like Artilysin. The company prioritizes microbiome health, focusing on healing rather than just treatment. Their target clients include individuals and healthcare providers concerned about microbiome protection. Lysando emphasizes a people-first a... Read More